Evidence map›Paper›PMID 39599491›Full record

ReviewPathogens (Basel, Switzerland)2024

CMV Retinitis in the Context of SARS-CoV-2 Infection: A Case Study and Comprehensive Review of Viral Interactions.

Emil Robert Stoicescu, Laura Andreea Ghenciu, Roxana Iacob, Adina Iuliana Ardelean, Ecaterina Dăescu, Ovidiu Alin Hațegan, Diana Manolescu, Emanuela Tudorache, Casiana Boru, Mirabela Dima

Abstract readCase ReportsReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emil Robert StoicescuRadiology and Medical Imaging University Clinic, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.ORCID 0000-0003-4620-3340
Laura Andreea GhenciuDepartment of Functional Sciences, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-5326-5438
Roxana IacobResearch Center for Medical Communication, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.ORCID 0000-0002-2894-712X
Adina Iuliana ArdeleanDiscipline of Ophtalmology, 'Victor Babes' University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
Ecaterina DăescuDepartment of Anatomy and Embriology, 'Victor Babes' University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
Ovidiu Alin HațeganDiscipline of Anatomy and Embriology, Medicine Faculty, "Vasile Goldis" Western University of Arad, Revolution Boulevard 94, 310025 Arad, Romania.
Diana ManolescuRadiology and Medical Imaging University Clinic, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Emanuela TudoracheCenter for Research and Innovation in Precision Medicine of Respiratory Diseases (CRIPMRD), 'Victor Babes' University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.ORCID 0000-0001-6667-3185
Casiana BoruDiscipline of Anatomy and Embriology, Medicine Faculty, "Vasile Goldis" Western University of Arad, Revolution Boulevard 94, 310025 Arad, Romania.
Mirabela DimaDepartment of Neonatology, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCytomegalovirus (CMV) retinitis is a sight-threatening condition predominantly affecting immunocompromised individuals, such as those with Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). We aimed to present an observational case report on CMV retinitis following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and to review the literature on the molecular and cellular changes in CMV and SARS-CoV-2 infections and how they may influence each other.

Indexed as

COVID-19Cytomegalovirus RetinitisSARS-CoV-2AdultAntiviral AgentsCytomegalovirusHumansImmunocompromised HostMaleAntiviral AgentsAIDS-related CMV retinitisAIDS-related ocular complicationsCMVCMV interactionCMV retinitisCOVID-19COVID-19 visual impairment riskscytomegaloviruscytomegalovirus reactivation in SARS-CoV-2HIVocular complications in COVID-19SARS-CoV-2SARS-CoV-2 coinfectionvalganciclovir treatment for CMV retinitis

Identifiers

PMID39599491
PMCPMC11597558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.